Trials / Conditions / T-cell Lymphomas
T-cell Lymphomas
6 registered clinical trials studyying T-cell Lymphomas — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Assessing Treatment of T-Cell Lymphoma With GW5282 in Combination With Golidocitinib (BEI-DOU3) NCT07496229 | Dizal Pharmaceuticals | Phase 1 / Phase 2 |
| Recruiting | A Study of Ruxolitinib and Duvelisib in People With Lymphoma NCT05010005 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Completed | Combination Therapy With Carfilzomib, Romidepsin, Lenalidomide in Patients With Relapsed or Refractory B- and NCT02341014 | Memorial Sloan Kettering Cancer Center | Phase 1 / Phase 2 |
| Terminated | Study of Infusion of Blood Cells (Lymphocytes) to Stimulate the Immune System to Fight Leukemia/Lymphoma NCT01685606 | Brown University | Phase 2 |
| Completed | A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL) NCT00611208 | Angimmune LLC | Phase 2 |
| Unknown | Orally Fludarabine, Adriamycin and Dexamethasone (FAD) in Newly Diagnosed Peripheral T-cell Lymphomas (PTCL) NCT00840385 | Fudan University | Phase 2 |